Date
Wednesday, June 17, 2026

Time

This activity is intended for psychiatrists, nurse practitioners, physician associates, primary care clinicians, and other healthcare professionals actively diagnosing and treating patients with mental health disorders.

• Describe the role of glutamatergic and neuroplasticity-based strategies in informing first-line treatment approaches for MDD
• Apply current evidence for newly approved and emerging treatments to personalize early-stage management of MDD
• Evaluate evidence-based augmentation approaches for patients with partial response, including pharmacologic and non-pharmacologic options
• Implement practical methods to enhance adherence, tolerability, and persistence through real-world strategies and lifestyle integration
• Use evidence-driven approaches for treatment sequencing and maintenance to achieve remission and sustain long-term functional recovery